Moorestown-based Tabula Rasa Healthcare has been approved for a new, $40 million revolving credit facility Bridge Bank in California. Terms of the facility were not disclosed, although one official with knowledge of the deal said that it is a five-year facility.
The new facility will support Tabula’s recent acquisition of medical therapy management specialist SinfoniaRX in September. Terms of that deal were also not disclosed.
Tabula Rasa specializes in delivering technology that enables precision medicine, and has nearly 200 employees. Its main product is the Medication Risk Mitigation Matrix, whichenables optimization of a patient’s medication regimen by combining clinical and pharmacology data, population-based algorithms, and extensive patient-specific data to deliver "precision medicine."
According to its most recent 10(k) filing, Tabula Rosa’s total revenue in 2016 was $94.1 million, an increase of 34 percent from the prior year.